Outcomes following pancreatic resection: Variability among high-volume providers

Surgery

Volumn 144, Issue 2, 2008, Pages 133-140

  Riall, Taylor S ^a   Nealon, William H ^a   Goodwin, James S ^a   Townsend Jr , Courtney M ^a   Freeman, Jean L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHRONIC PANCREATITIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREAS RESECTION; PANCREAS TUMOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; FEMALE; HOSPITAL MORTALITY; HOSPITALS; HUMANS; INSURANCE, HOSPITALIZATION; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PANCREATECTOMY; SURGICAL PROCEDURES, ELECTIVE;

EID: 47549098784     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.03.041     Document Type: Article

References (33)

1. Donabedian A. The quality of care. How can it be assessed?. JAMA 260 (1988) 1743-1748
2. Donabedian A. Quality assurance. Structure, process and outcome. Nurs Stand (1992) 7:(11 Suppl QA):4-5
3. Fong Y., Gonen N., Rubin D., Radzyner M., and Brennan M.F. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 242 (2005) 540-547
4. Gordon T.A., Burleyson G.P., Tielsch J.M., and Cameron J.L. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 221 (1995) 43-49
5. Lieberman M.D., Kilburn H., Lindsey M., and Brennan M.F. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 222 (1995) 638-645
6. Ho V., and Heslin M.J. Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy. Ann Surg 237 (2003) 509-514
7. van Heek N.T., Kuhlmann K.F.D., Scholten R.J., et al. Hospital volume and mortality after pancreatic resection. A systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242 (2005) 781-790
8. Birkmeyer J.D., Sun Y., Goldfaden A., Birkmeyer N.J.O., and Stukel T.A. Volume and process of care in high-risk cancer surgery. Cancer 106 (2006) 2476-2481
9. Kotwall C.A., Maxwell J.G., Brinker C.C., Koch G.G., and Covington D.L. National estimates of mortality rates for radical pancreaticoduodenectomy in 25,000 patients. Ann Surg Oncol 9 (2002) 847-854
10. Gouma D.J., van Geenen R.C.I., van Gulik T.M., et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 6 (2000) 786-795
11. Gordon T.A., Bowman H.M., Tielsch J.M., Bass E.B., Burleyson G.P., and Cameron J.L. Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg 228 (1998) 71-78
12. Sosa J.A., Bowman H.M., Bass E.B., et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 228 (1998) 429-438
13. Birkmeyer J.D., Warshaw A.L., Finlayson S.R.G., Grove M.R., and Tosteson A.N.A. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 126 (1999) 178-183
14. Riall T.S., Eschbach K.A., Townsend C.M., Nealon W.H., Freeman J.L., and Goodwin J.S. Trends and disparities in regionalization of pancreatic resection. J Gastrointest Surg 11 (2007) 1242-1251
15. Meguid R.A., Ahuja N., and Chang D.C. What constitutes a high-volume hospital for pancreatic resection?. J Am Coll Surg 206 (2008) 622.e1-622.e9 Epub ahead of print
16. Birkmeyer J.D., and Dimick J.B. Potential benefits of the new Leapfrog standards: effect of process and outcomes measures. Surgery 135 (2004) 569-575
17. Bunker J.P., Luft H.S., and Enthoven A. Should surgery be regionalized?. Surg Clin N Am 62 (1982) 657-668
18. Birkmeyer J.D. Raising the bar for pancreaticoduodenectomy. Ann Surg Oncol 9 (2002) 826-827
19. Afsari A., Zhandoug Z., Young S., Ferguson L., Silapaswan S., and Mittal V. Outcome analysis of pancreaticoduodenectomy at a community hospital. Am Surg 68 (2002) 281-284
20. Chew D.K., and Attiyeh F.F. Experience with the Whipple procedure (pancreaticoduodenectomy) in a university-affiliated community hospital. Am J Surg 174 (1997) 312-315
21. Metreveli R.E., Sahm K., Abdel-Misih R., and Petrelli N.J. Major pancreatic resections for suspected cancer in a community-based teaching hospital: lessons learned. J Surg Oncol 95 (2007) 201-206
22. Maa J., Gosnell J.E., Gibbs V.C., and Harris H.W. Exporting excellence for Whipple resection to refine the Leapfrog Initiative. J Surg. Res 138 (2007) 189-197
23. Hospital Data: Texas Health Care Information Collection Center for Health Statistics [Internet]. Austin (TX): Texas Department of State Health Services 1999- [cited 2007 Mar 17]. Available from: http://www.dshs.state.tx.us/thcic/Hospitals/HospitalData.shtm.
24. Kennedy E.P., Rosato E.L., Sauter P.K., Rosenberg L.M., Doria C., Marino I.R., et al. Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution-the first step in multidisciplinary team building. J Am Coll Surg 204 (2007) 917-923
25. Winter J.M., Cameron J.L., Campbell K.A., et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10 (2006) 1199-1210
26. Hutter M.M., Glasgow R.E., and Mulvihill S.J. Does the participation of a surgical trainee impact patient outcomes? A study of major pancreatic resections in California. Surgery 128 (2000) 286-292
27. Pitt H.A., Murray K.P., Bowman H.M., Coleman J., Gordon T.A., Yeo C.J., et al. Clinical pathway implementation improves outcomes for complex biliary surgery. Surgery 156 (1999) 751-756
28. Porter G.A., Pisters P.W., Mansyur C., Bisanz A., Reyna K., Stanford P., et al. Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol 7 (2000) 484-489
29. Campbell H., Hotchkiss R., Bradshaw N., and Porteous M. Integrated care pathways. BMJ 316 (1998) 133-137
30. Lillemoe K.D., Cameron J.L., Kim M.P., Campbell K.A., Sauter P.K., Coleman J., et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 8 (2004) 766-772
31. Büchler M.W., Bassi C., Fingerhut A., and Klempa I. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy?. Ann Surg 234 (2001) 262-263
32. Yeo C.J., Lillemoe K.D., Sauter P.K., Coleman J., Sohn T.A., Campbell K.A., et al. Does prophylactic octreotide really decrease the rates of pancreatic fistula and other complications following pancreaticoduodenectomy?. Ann Surg 232 (2000) 419-429
33. Yeo C.J., Barry M.K., Sauter P.K., Sostre S., Lillemoe K.D., Pitt H.A., et al. Erythromycin accelerates gastric emptying following pancreaticoduodenectomy: a prospective, randomized placebo-controlled trial. Ann Surg 218 (1993) 229-238